高级检索
当前位置: 首页 > 详情页

Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Univ Engn, Med Coll, Dept Pathol, Handan, Hebei, Peoples R China [2]Hebei Univ Engn, Dept Oncol, Affiliated Hosp, Handan, Hebei, Peoples R China [3]Hebei Univ Engn, Med Coll, Microscope Room, Handan, Hebei, Peoples R China
出处:
ISSN:

关键词: in vivo experiments miR-211-5p SOX11 thyroid cancer (TC)

摘要:
PurposeThis study was aimed to investigate the relationship between miR-211-5p and SOX11, and the effects of their interaction on the proliferation, viability, and invasion of human thyroid cancer (TC) cells. MethodsWe used quantitative real-time PCR (qRT-PCR) to determine the expression of miR-211-5p and SOX11mRNA in the thyroid tumorous and the adjacent tissues. The target relationship between miR-211-5p and SOX11 was confirmed using dual luciferase reporter gene assay. Flow cytometry, colony formation assay, Transwell assay, and MTT assay were performed to determine the cell-cycle progression, cell apoptosis, proliferation and invasion, respectively. In addition, the tumor formation assay in nude mice was done to assess the effect of miR-211-5p on TC development in vivo. ResultsMiR-211-5p was underexpressed, whereas SOX11 was overexpressed in TC. The overexpression of miR-211-5p inhibited the expression of SOX11. The cell cycle was arrested and the proliferation as well as invasiveness was suppressed by exogenous miR-211-5p in TC cell line. The antitumor role of miR-211-5p was proved by the animal experiment. ConclusionMiR-211-5p affected the viability, proliferation and invasion of TC by negatively regulating SOX11 expression.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 医学实验技术
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 医学实验技术
JCR分区:
出版当年[2018]版:
Q3 MEDICAL LABORATORY TECHNOLOGY
最新[2023]版:
Q2 MEDICAL LABORATORY TECHNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Hebei Univ Engn, Med Coll, Dept Pathol, Handan, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Hebei Univ Engn, Med Coll, Dept Pathol, Handan, Hebei, Peoples R China [*1]Department of Pathology, MedicalCollege of Hebei University of Engineering,Handan, Hebei Province, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15100 今日访问量:0 总访问量:960 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号